| Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade N McGranahan, AJS Furness, R Rosenthal, S Ramskov, R Lyngaa, ... Science 351 (6280), 1463-1469, 2016 | 2980 | 2016 |
| Tracking the evolution of non–small-cell lung cancer M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ... New England Journal of Medicine 376 (22), 2109-2121, 2017 | 2180 | 2017 |
| Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ... Nature 545 (7655), 446-451, 2017 | 1702 | 2017 |
| Allele-specific HLA loss and immune escape in lung cancer evolution N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ... Cell 171 (6), 1259-1271. e11, 2017 | 1162 | 2017 |
| Neoantigen-directed immune escape in lung cancer evolution R Rosenthal, EL Cadieux, R Salgado, MA Bakir, DA Moore, CT Hiley, ... Nature 567 (7749), 479-485, 2019 | 730 | 2019 |
| Fc effector function contributes to the activity of human anti-CTLA-4 antibodies FA Vargas, AJS Furness, K Litchfield, K Joshi, R Rosenthal, E Ghorani, ... Cancer cell 33 (4), 649-663. e4, 2018 | 540 | 2018 |
| Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ... Immunity 46 (4), 577-586, 2017 | 413 | 2017 |
| Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine C Hiley, EC de Bruin, N McGranahan, C Swanton Genome biology 15, 1-10, 2014 | 228 | 2014 |
| Geospatial immune variability illuminates differential evolution of lung adenocarcinoma K AbdulJabbar, SEA Raza, R Rosenthal, M Jamal-Hanjani, S Veeriah, ... Nature medicine 26 (7), 1054-1062, 2020 | 227 | 2020 |
| Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse F Chemi, DG Rothwell, N McGranahan, S Gulati, C Abbosh, SP Pearce, ... Nature medicine 25 (10), 1534-1539, 2019 | 173 | 2019 |
| Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer K Joshi, MR de Massy, M Ismail, JL Reading, I Uddin, A Woolston, ... Nature medicine 25 (10), 1549-1559, 2019 | 167 | 2019 |
| Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease CT Hiley, J Le Quesne, G Santis, R Sharpe, DG de Castro, G Middleton, ... The Lancet 388 (10048), 1002-1011, 2016 | 163 | 2016 |
| Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma L Au, E Hatipoglu, MR de Massy, K Litchfield, G Beattie, A Rowan, ... Cancer cell 39 (11), 1497-1518. e11, 2021 | 152 | 2021 |
| Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer Z Kos, E Roblin, RS Kim, S Michiels, BD Gallas, W Chen, KK van de Vijver, ... NPJ breast cancer 6 (1), 17, 2020 | 131 | 2020 |
| Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome MML Green, CT Hiley, JH Shanks, IC Bottomley, CML West, RA Cowan, ... International Journal of Radiation Oncology* Biology* Physics 67 (1), 84-90, 2007 | 108 | 2007 |
| A clonal expression biomarker associates with lung cancer mortality D Biswas, NJ Birkbak, R Rosenthal, CT Hiley, EL Lim, K Papp, S Boeing, ... Nature medicine 25 (10), 1540-1548, 2019 | 88 | 2019 |
| PRSS3 promotes tumour growth and metastasis of human pancreatic cancer G Jiang, F Cao, G Ren, D Gao, V Bhakta, Y Zhang, H Cao, Z Dong, ... Gut 59 (11), 1535-1544, 2010 | 87 | 2010 |
| The T cell differentiation landscape is shaped by tumour mutations in lung cancer E Ghorani, JL Reading, JY Henry, MR Massy, R Rosenthal, V Turati, ... Nature cancer 1 (5), 546-561, 2020 | 86 | 2020 |
| Antibodies against endogenous retroviruses promote lung cancer immunotherapy KW Ng, J Boumelha, KSS Enfield, J Almagro, H Cha, O Pich, T Karasaki, ... Nature 616 (7957), 563-573, 2023 | 84 | 2023 |
| Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA C Abbosh, AM Frankell, T Harrison, J Kisistok, A Garnett, L Johnson, ... Nature 616 (7957), 553-562, 2023 | 83 | 2023 |
